Sonoma Pharmaceuticals (SNOA) Interest Expenses (2010 - 2021)

Sonoma Pharmaceuticals' Interest Expenses history runs 12 years deep, the most recent figure standing at $1000.0 for Q2 2021.

• In Q2 2021, Interest Expenses changed N/A year-over-year to $1000.0; the TTM figure through Mar 2022 stood at $1000.0 (down 88.89% YoY), while the FY2021 annual figure was $12000.0, down 25.0% from the prior year.
• Interest Expenses was $1000.0 for Q2 2021 at Sonoma Pharmaceuticals, down from $5000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $12000.0 in Q2 2018 to a low of $1000.0 in Q1 2017.
• Historically, Interest Expenses has averaged $6250.0 across 5 years, with a median of $7000.0 in 2018.
• The sharpest annual moves came in 2017 and 2019: Interest Expenses surged 900.0% in 2017, then sank 85.71% in 2019.
• A 5-year view of Interest Expenses shows it stood at $11000.0 in 2017, then slumped by 36.36% to $7000.0 in 2018, then slumped by 85.71% to $1000.0 in 2019, then jumped by 400.0% to $5000.0 in 2020, then plunged by 80.0% to $1000.0 in 2021.
• The last three Interest Expenses figures came in at $1000.0 (Q2 2021), $5000.0 (Q4 2020), and $4000.0 (Q3 2020), per Business Quant data.